Cipla has received final USFDA approval for its Abbreviated New Drug Application (ANDA) for Darifenacin extended-release tablets. Darifenacin extended-release tablets are AB-rated generic equivalents of […]
Glenmark Pharmaceuticals has received final approval from USFDA for its generic version of AstraZeneca’s Xylocaine ointment. The approval is for Lidocaine Ointment USP, 5 per […]
Cipla has received final USFDA approval to market generic Bupropion Hydrochloride extended release tablets used for treatment of major depressive disorder through its subsidiary InvaGen […]
Lupin has received Central Drugs Standard Control Organisation (CDSCO) approval for Acotiamide 100 mg tablets used for the treatment of indigestion. The drug Acotiamide is […]
Piramal Enterprises has entered into an agreement to acquire the entire stake in US-based Ash Stevens – a contract manufacturing organization in an all cash […]
Strides Shasun has completed acquisition of a controlling stake in Australia-based Generic Partners Holdings. The company has acquired 51 per cent stake in Australia’s Generic […]
Aurobindo Pharma has received final USFDA approval to manufacture and market Linezolid injection which is an anti-infective and is used to treat infections caused by […]
Aurobindo Pharma has received final USFDA approval for Rosuvastatin calcium tablets which are prescribed for lowering cholesterol. Rosuvastatin calcium tablets are the generic version of […]
Claris Lifesciences has received USFDA approval for generic anaesthetic Bupivacaine injection. The new drug Bupivacaine hydrochloride will be sold in 8.25 per cent dextrose injection […]
Glenmark Pharma has received final USFDA approval for anti-fungal ointment nystatin and triamcinolone acetonide.The company also received tentative approval for Olmesartan medoxomil, used for the […]
Copyright © 2026 | WordPress Theme by MH Themes